Lonza | LONN - Current Liabilities

Stock Price
520.60
Daily Change
-15.80 -2.95%
Monthly
-5.69%
Yearly
-10.83%
Q1 Forecast
523.37

Lonza reported CHF3.58B in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akzo Nobel EUR 4.21B 631M Dec/2025
Alcon AG USD 2.99B 566M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
BASF EUR 17.25B 932M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Beiersdorf EUR 3.77B 6.12B Jun/2025
Covestro EUR 4.17B 124M Sep/2025
Demant DKK 7.42B 1.63B Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 5.76B 98.85M Sep/2025
Geberit CHF 854.7M 192.6M Dec/2024
Genmab DKK 629M 127M Jun/2025
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GN Store Nord DKK 7.32B 153M Dec/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Johnson Matthey GBP 2.32B 155M Dec/2025
Merck EUR 8.64B 1.22B Sep/2025
Novartis USD 32B 286M Sep/2025
Philips EUR 7.51B 479M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Sika AG CHF 2.8B 211.8M Jun/2025
Smith & Nephew USD 1.54B 236M Dec/2025
Solvay EUR 1.56B 49M Sep/2025
UCB EUR 3.53B 731M Dec/2024